|
Q2 FY2026
As of Jul 3, 2026
|
Q1 FY2026
As of Apr 3, 2026
|
Q4 FY2025
As of Jan 2, 2026
|
Q3 FY2025
As of Oct 3, 2025
|
Q2 FY2025
As of Jul 4, 2025
|
Q1 FY2025
As of Apr 4, 2025
|
Q4 FY2024
As of Jan 3, 2025
|
Q3 FY2024
As of Sep 27, 2024
|
Q2 FY2024
As of Jun 28, 2024
|
Q1 FY2024
As of Mar 29, 2024
|
Q4 FY2023
As of Dec 29, 2023
|
Q3 FY2023
As of Sep 29, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 30, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jul 1, 2022
|
Q1 FY2022
As of Apr 1, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Oct 1, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable (net of allowances of $3,265 and $2,881, respectively) | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaids and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Lease right-of-use assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Trademarks and brands, net | ||||||||||||||||||||
| Trademarks and brands, net | ||||||||||||||||||||
| Customer and distributor relationships, net | ||||||||||||||||||||
| Core technologies, net | ||||||||||||||||||||
| Total trademarks and brands, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Revolver | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Long-term debt less current portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock, $0.001 par value — $10,000 authorized and no shares issued or outstanding as of July 3, 2026 and January 2, 2026 | ||||||||||||||||||||
| Common stock, $0.001 par value — 90,000 authorized; $42,921 shares issued and $42,031 outstanding as of July 3, 2026; $42,692 shares issued and $41,802 outstanding as of January 2, 2026 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost; $890 common shares as of July 3, 2026 and January 2, 2026 | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
